Home » Topics » BioWorld MedTech

BioWorld MedTech
RSS

FDA CONSIDERS COLLAGEN LABEL CHANGE

Sep. 4, 1991

BTGC RAISES $2.9 MILLION IN SECOND CLOSING

Sep. 4, 1991

USDA APPROVES CALF'S SCOURS DRUG

Sep. 4, 1991

POSSIBLE PATH TO BETTER IMMUNOSUPPRESSANTS

Sep. 3, 1991

EMBREX FILES FOR 1.7 MILLION-SHARE IPO

Sep. 3, 1991

IMMUNOMEDICS BINDS RADIOISOTOPE TO MAb

Sep. 3, 1991

APPOINTMENTS AND ADVANCEMENTS

Sep. 3, 1991

AMENDED COMPLAINTS TO REGENERON SUITS

Sep. 3, 1991

SHAMAN DRUGS FROM TROPICAL PLANTS

Sep. 3, 1991

'VIRTUALLY UNLIMITED' ANTIBODY FRAGMENTS

Aug. 30, 1991

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 22, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 22, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...